Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, Tomar D, Woodruff MC, Simon Z, Bugrovsky R, Blalock EL, Scharer CD, Tipton CM, Wei C, Lim SS, Petri M, Niewold TB, Anolik JH, Gibson G, Eun-Hyung Lee F, Boss JM, Lund FE, Sanz I.

Immunity. 2020 Jan 14;52(1):203. doi: 10.1016/j.immuni.2019.12.005. No abstract available.

PMID:
31940271
2.

Threat bias and resting state functional connectivity of the amygdala and bed nucleus stria terminalis.

Jenks SK, Zhang S, Li CR, Hu S.

J Psychiatr Res. 2019 Dec 31;122:54-63. doi: 10.1016/j.jpsychires.2019.12.017. [Epub ahead of print]

PMID:
31927266
3.

Heart rate and heart rate variability in emergency medicine.

Jenks S, Frank Peacock W, Cornelius AP, Shafer S, Pillow MT, Rayasam SS.

Am J Emerg Med. 2019 Nov 18. pii: S0735-6757(19)30689-8. doi: 10.1016/j.ajem.2019.10.035. [Epub ahead of print]

PMID:
31836346
4.

Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease.

Cashman KS, Jenks SA, Woodruff MC, Tomar D, Tipton CM, Scharer CD, Eun-Hyung Lee F, Boss JM, Sanz I.

Immunol Rev. 2019 Nov;292(1):76-89. doi: 10.1111/imr.12820. Epub 2019 Nov 22. Review.

PMID:
31755562
5.

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations.

Sanz I, Wei C, Jenks SA, Cashman KS, Tipton C, Woodruff MC, Hom J, Lee FE.

Front Immunol. 2019 Oct 18;10:2458. doi: 10.3389/fimmu.2019.02458. eCollection 2019. Review.

6.

Epigenetic programming underpins B cell dysfunction in human SLE.

Scharer CD, Blalock EL, Mi T, Barwick BG, Jenks SA, Deguchi T, Cashman KS, Neary BE, Patterson DG, Hicks SL, Khosroshahi A, Eun-Hyung Lee F, Wei C, Sanz I, Boss JM.

Nat Immunol. 2019 Aug;20(8):1071-1082. doi: 10.1038/s41590-019-0419-9. Epub 2019 Jul 1.

7.

IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.

Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, Rosal-Vela A, Botta D, Bradley JE, Wojciechowski W, Ptacek T, Danila MI, Edberg JC, Bridges SL Jr, Kimberly RP, Chatham WW, Schoeb TR, Rosenberg AF, Boss JM, Sanz I, Lund FE.

Elife. 2019 May 15;8. pii: e41641. doi: 10.7554/eLife.41641.

8.

Imaging the effects of age on proactive control in healthy adults.

Hu S, Job M, Jenks SK, Chao HH, Li CR.

Brain Imaging Behav. 2019 Dec;13(6):1526-1537. doi: 10.1007/s11682-019-00103-w.

9.

Extrafollicular responses in humans and SLE.

Jenks SA, Cashman KS, Woodruff MC, Lee FE, Sanz I.

Immunol Rev. 2019 Mar;288(1):136-148. doi: 10.1111/imr.12741. Review.

PMID:
30874345
10.

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, Tomar D, Woodruff MC, Simon Z, Bugrovsky R, Blalock EL, Scharer CD, Tipton CM, Wei C, Lim SS, Petri M, Niewold TB, Anolik JH, Gibson G, Lee FE, Boss JM, Lund FE, Sanz I.

Immunity. 2018 Oct 16;49(4):725-739.e6. doi: 10.1016/j.immuni.2018.08.015. Epub 2018 Oct 9. Erratum in: Immunity. 2020 Jan 14;52(1):203.

11.

Scientists Seek Uniform Reference Standards for Sequencing DNA of Cancers.

Jenks S.

J Natl Cancer Inst. 2017 Jun 1;109(6). doi: 10.1093/jnci/djx127. No abstract available.

PMID:
30053243
12.

Patient Consent: Defining Control of Genetic Information.

Jenks S.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx170. No abstract available.

PMID:
29117393
13.

New Gene-Editing Tool Slowly Advances Into the Clinic.

Jenks S.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx220. No abstract available.

PMID:
29117363
14.

Improving Children's Access to Cancer Clinical Trials.

Jenks S.

J Natl Cancer Inst. 2017 Feb 1;109(2). doi: 10.1093/jnci/djx021. No abstract available.

PMID:
28800697
15.

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Jenks SJ, Conway BR, McLachlan S, Teoh WL, Williamson RM, Webb DJ, Welsh P, Sattar N, Strachan MWJ, Price JF.

Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.

16.

Experts To Address Rare, Toxic Downside of Immunotherapy.

Jenks S.

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djx079. No abstract available.

PMID:
30053210
17.

Young Man With Sudden Onset of Shortness of Breath.

Gallegos M, Jenks S.

Ann Emerg Med. 2017 Feb;69(2):264-272. doi: 10.1016/j.annemergmed.2016.07.005. No abstract available.

PMID:
28126126
18.

A Snapshot of Urban Adolescent Women's Contraceptive Knowledge at the Onset of a Community Long-Acting Reversible Contraceptive Promotion Initiative.

Greenberg KB, Jenks SC, Piazza N, Malibiran BR, Aligne CA.

J Pediatr Adolesc Gynecol. 2017 Aug;30(4):474-478. doi: 10.1016/j.jpag.2017.01.003. Epub 2017 Jan 12.

PMID:
28088438
19.

The Cancer Moonshot: Poised To Make Advances.

Jenks S.

J Natl Cancer Inst. 2016 Dec 16;108(12). pii: djw310. Print 2016 Dec. No abstract available.

PMID:
27986889
20.

The Regulation of Inherently Autoreactive VH4-34-Expressing B Cells in Individuals Living in a Malaria-Endemic Area of West Africa.

Hart GT, Akkaya M, Chida AS, Wei C, Jenks SA, Tipton C, He C, Wendel BS, Skinner J, Arora G, Kayentao K, Ongoiba A, Doumbo O, Traore B, Narum DL, Jiang N, Crompton PD, Sanz I, Pierce SK.

J Immunol. 2016 Nov 15;197(10):3841-3849. Epub 2016 Oct 19.

21.

Tracking Tumor Resistance: The Early Promise of "Liquid" Cancer Tests.

Jenks S.

J Natl Cancer Inst. 2016 Sep 14;108(9). pii: djw220. doi: 10.1093/jnci/djw220. Print 2016 Sep. No abstract available.

PMID:
27628661
22.

Physical Activity Associated With Fewer Cancers.

Jenks S.

J Natl Cancer Inst. 2016 Aug 10;108(8). pii: djw195. doi: 10.1093/jnci/djw195. Print 2016 Aug. No abstract available.

23.

Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.

Bird TG, Dimitropoulou P, Turner RM, Jenks SJ, Cusack P, Hey S, Blunsum A, Kelly S, Sturgeon C, Hayes PC, Bird SM.

PLoS One. 2016 Jun 16;11(6):e0156801. doi: 10.1371/journal.pone.0156801. eCollection 2016.

24.

Shock Therapy for Late-Stage Pancreatic Cancer Gets Closer Look.

Jenks S.

J Natl Cancer Inst. 2016 Jun 2;108(6):djw159. doi: 10.1093/jnci/djw159. Print 2016 Jun. No abstract available.

PMID:
27257026
25.

Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.

Betz BB, Jenks SJ, Cronshaw AD, Lamont DJ, Cairns C, Manning JR, Goddard J, Webb DJ, Mullins JJ, Hughes J, McLachlan S, Strachan MWJ, Price JF, Conway BR.

Kidney Int. 2016 May;89(5):1125-1135. doi: 10.1016/j.kint.2016.01.015. Epub 2016 Mar 7.

PMID:
27083286
26.

Digital Imaging of the Breast: Is a Synthetic View Better?

Jenks S.

J Natl Cancer Inst. 2016 Apr 2;108(4). pii: djw115. doi: 10.1093/jnci/djw115. Print 2016 Apr. No abstract available.

PMID:
27038116
27.

Is Lung Cancer Incidence Increasing in Never-Smokers?

Jenks S.

J Natl Cancer Inst. 2015 Dec 27;108(1). pii: djv418. doi: 10.1093/jnci/djv418. Print 2016 Jan. No abstract available.

PMID:
26711663
28.

Studying Pets' Cancers May Yield Health Benefits For Humans.

Jenks S.

J Natl Cancer Inst. 2015 Nov 4;107(11):djv355. doi: 10.1093/jnci/djv355. Print 2015 Nov. No abstract available.

PMID:
26538624
29.

Mammography Screening Still Brings Mixed Advice.

Jenks S.

J Natl Cancer Inst. 2015 Aug 4;107(8). pii: djv232. doi: 10.1093/jnci/djv232. Print 2015 Aug. No abstract available.

30.

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus.

Tipton CM, Fucile CF, Darce J, Chida A, Ichikawa T, Gregoretti I, Schieferl S, Hom J, Jenks S, Feldman RJ, Mehr R, Wei C, Lee FE, Cheung WC, Rosenberg AF, Sanz I.

Nat Immunol. 2015 Jul;16(7):755-65. doi: 10.1038/ni.3175. Epub 2015 May 25.

31.

Understanding random cancers.

Jenks S.

J Natl Cancer Inst. 2015 May 9;107(5). pii: djv144. doi: 10.1093/jnci/djv144. Print 2015 May. No abstract available.

PMID:
25957447
32.

Polychromatic flow cytometry in evaluating rheumatic disease patients.

Wei C, Jenks S, Sanz I.

Arthritis Res Ther. 2015 Mar 5;17:46. doi: 10.1186/s13075-015-0561-1. Review.

33.

Rising double-mastectomy rates attract increasing scrutiny.

Jenks S.

J Natl Cancer Inst. 2015 Feb 12;107(2). pii: djv027. doi: 10.1093/jnci/djv027. Print 2015 Feb. No abstract available.

PMID:
25677042
34.

Renewed focus on preventing gastric cancer.

Jenks S.

J Natl Cancer Inst. 2015 Jan 6;107(1):501. doi: 10.1093/jnci/dju501. Print 2015 Jan. No abstract available.

PMID:
25564606
35.

Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis.

Jenks S, Yeoh SE, Conway BR.

Cochrane Database Syst Rev. 2014;(12):CD002944. doi: 10.1002/14651858.CD002944.pub2. Epub 2014 Dec 5. Review.

PMID:
25478936
36.

New therapy targets resistant non-small-cell lung cancers.

Jenks S.

J Natl Cancer Inst. 2014 Nov 23;106(11). pii: dju393. doi: 10.1093/jnci/dju393. Print 2014 Nov. No abstract available.

PMID:
25421346
37.

Seeing the difference.

Escott ME, Gleisberg GR, Gillum LS, Cosper J, Traynor KM, Aulbert L, Vartanian L, Jenks SP, Monroe BJ.

JEMS. 2014 Aug;39(8):34-9. No abstract available.

PMID:
25204113
38.

Researchers push back against overhauling clinical trials.

Jenks S.

J Natl Cancer Inst. 2014 Aug 13;106(8). pii: dju274. doi: 10.1093/jnci/dju274. Print 2014 Aug. No abstract available.

PMID:
25122733
39.

Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.

Roberts ME, Kaminski D, Jenks SA, Maguire C, Ching K, Burbelo PD, Iadarola MJ, Rosenberg A, Coca A, Anolik J, Sanz I.

Arthritis Rheumatol. 2014 Sep;66(9):2558-69. doi: 10.1002/art.38734.

40.

Melanoma treatment's changing landscape.

Jenks S.

J Natl Cancer Inst. 2014 Jun 6;106(6):dju176. doi: 10.1093/jnci/dju176. Print 2014 Jun. No abstract available.

PMID:
24907389
41.

Storytelling's power in cancer treatment.

Jenks S.

J Natl Cancer Inst. 2014 May 9;106(5). pii: dju141. doi: 10.1093/jnci/dju141. No abstract available.

42.

Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.

Jenks SJ, Conway BR, Hor TJ, Williamson RM, McLachlan S, Robertson C, Morling JR, Strachan MW, Price JF.

Diabet Med. 2014 Sep;31(9):1039-46. doi: 10.1111/dme.12456. Epub 2014 Apr 16.

PMID:
24684407
43.

Downgrading cancer definitions: overdiagnosis fuels the discussion.

Jenks S.

J Natl Cancer Inst. 2014 Mar;106(3):dju070. doi: 10.1093/jnci/dju070. Epub 2014 Mar 7. No abstract available.

PMID:
24610912
44.

Setting the bar higher for ovarian cancer survival.

Jenks S.

J Natl Cancer Inst. 2014 Feb;106(2):dju037. doi: 10.1093/jnci/dju037. No abstract available.

PMID:
24511114
45.

Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Richardson C, Chida AS, Adlowitz D, Silver L, Fox E, Jenks SA, Palmer E, Wang Y, Heimburg-Molinaro J, Li QZ, Mohan C, Cummings R, Tipton C, Sanz I.

J Immunol. 2013 Nov 15;191(10):4926-39. doi: 10.4049/jimmunol.1202263. Epub 2013 Oct 9.

46.

Shaking tobacco's residual grip: endgame strategies emerge.

Jenks S.

J Natl Cancer Inst. 2013 Sep 18;105(18):1336-8. doi: 10.1093/jnci/djt262. Epub 2013 Aug 29. No abstract available.

PMID:
23990670
47.

9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

Jenks SA, Palmer EM, Marin EY, Hartson L, Chida AS, Richardson C, Sanz I.

Arthritis Rheum. 2013 Dec;65(12):3165-75. doi: 10.1002/art.38138.

48.

Cancer experts issue first guidelines for survivors, rare cancer.

Jenks S.

J Natl Cancer Inst. 2013 Jul 17;105(14):995-6. doi: 10.1093/jnci/djt193. Epub 2013 Jul 11. No abstract available.

PMID:
23847244
49.

Bartering for time: realism versus hope.

Jenks S.

J Natl Cancer Inst. 2013 Jul 17;105(14):996-7. doi: 10.1093/jnci/djt194. Epub 2013 Jul 11. No abstract available.

PMID:
23847239
50.

Navigating the genome's "dark matter".

Jenks S.

J Natl Cancer Inst. 2013 May 15;105(10):673-4. doi: 10.1093/jnci/djt109. Epub 2013 May 6. No abstract available.

PMID:
23650624

Supplemental Content

Support Center